Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacologically targeting transient receptor potential channels for seizures and epilepsy: Emerging preclinical evidence of druggability
Jianxiong Jiang, Ying Yu
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108384-108384
Open Access | Times Cited: 11

Showing 11 citing articles:

TTD: Therapeutic Target Database describing target druggability information
Ying Zhou, Yintao Zhang, Donghai Zhao, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1465-D1477
Open Access | Times Cited: 229
Deep learning-based multi-head self-attention model for human epilepsy identification from EEG signal for biomedical traits
Ashit Kumar Dutta, Mohan Raparthi, Mahmood Alsaadi, et al.
Multimedia Tools and Applications (2024) Vol. 83, Iss. 33, pp. 80201-80223
Closed Access | Times Cited: 12
Mechanism of NLRP3 Inflammasome in Epilepsy and Related Therapeutic Agents
Juan Chen, Yuan Gao, Ning Liu, et al.
Neuroscience (2024) Vol. 546, pp. 157-177
Closed Access | Times Cited: 8
Multifaceted targets of cannabidiol in epilepsy: Modulating glutamate signaling and beyond
Pukar Khanal, Vishal S. Patil, Kunal Bhattacharya, et al.
Computers in Biology and Medicine (2024) Vol. 179, pp. 108898-108898
Closed Access | Times Cited: 6
TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates
Katarzyna Socała, Marcin Jakubiec, Michał Abram, et al.
Progress in Neurobiology (2024) Vol. 240, pp. 102634-102634
Open Access | Times Cited: 4
Emerging Trends in Modulation of Transient Receptor Potential Canonical 6 Channels as Therapeutic Targets
Ayush Sharma, Snehal S. Patel, Mithun Singh Rajput
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
A Combined Ligand- and Structure-Based Virtual Screening To Identify Novel NaV1.2 Blockers: In Vitro Patch Clamp Validation and In Vivo Anticonvulsant Activity
Manuel A. Llanos, Nicolás Enrique, Vega Esteban-López, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 22, pp. 7083-7096
Closed Access | Times Cited: 7
Recent Advances in Understanding the Mechanistic Role of Transient Receptor Potential Ion Channels in Patients With Hypertension
Francisco J. Rios, Raquel Sarafian, Lívia L. Camargo, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 12, pp. 1859-1873
Closed Access | Times Cited: 4
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel
Vijay K. Boda, Nelufar Yasmen, Jianxiong Jiang, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2510-2544
Closed Access | Times Cited: 1
Inhibition of TRPC3 channels suppresses seizure susceptibility in the genetically-epilepsy prone rats
Gleice Kelli Silva-Cardoso, Vijay K. Boda, Wěi Li, et al.
European Journal of Pharmacology (2024) Vol. 977, pp. 176722-176722
Closed Access | Times Cited: 1
Microglial TRPV1 in epilepsy: Is it druggable for new antiepileptic treatment?
JIAO HU, Jialu Mo, Xianglin Cheng
Biocell (2023) Vol. 47, Iss. 8, pp. 1689-1701
Open Access | Times Cited: 3
Page 1

Scroll to top